1-5 of 5
Henrik J. Ditzel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19

Maria Ormhøj, Irene Scarfò, Maria L. Cabral, Stefanie R. Bailey, Selena J. Lorrey, Amanda A. Bouffard, Ana P. Castano, Rebecca C. Larson, Lauren S. Riley, Andrea Schmidts, Bryan D. Choi, Rikke S. Andersen, Oriane Cédile, Charlotte G. Nyvold, Jacob H. Christensen, Morten F. Gjerstorff, Henrik J. Ditzel, David M. Weinstock, Torben Barington, Matthew J. Frigault, Marcela V. Maus
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2286.
https://doi.org/10.1158/1078-0432.CCR-24-1059
Published: 15 May 2024
View article titled, Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Open the PDF for Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 in another window
Journal Articles

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19

Maria Ormhøj, Irene Scarfò, Maria L. Cabral, Stefanie R. Bailey, Selena J. Lorrey, Amanda A. Bouffard, Ana P. Castano, Rebecca C. Larson, Lauren S. Riley, Andrea Schmidts, Bryan D. Choi, Rikke S. Andersen, Oriane Cédile, Charlotte G. Nyvold, Jacob H. Christensen, Morten F. Gjerstorff, Henrik J. Ditzel, David M. Weinstock, Torben Barington, Matthew J. Frigault, Marcela V. Maus
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 7046–7057.
https://doi.org/10.1158/1078-0432.CCR-19-1337
Published: 01 December 2019
View article titled, Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19
Open the PDF for Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 in another window
Includes: Supplementary data
Journal Articles

High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer

Carla L. Alves, Daniel Elias, Maria Lyng, Martin Bak, Tove Kirkegaard, Anne E. Lykkesfeldt, Henrik J. Ditzel
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (22): 5514–5526.
https://doi.org/10.1158/1078-0432.CCR-15-1984
Published: 14 November 2016
View article titled, High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer
Open the PDF for High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Detecting Plasma Tumor DNA in Early-Stage Breast Cancer—Letter

Annette R. Kodahl, Niels Pallisgaard, Anne Marie B. Jylling, Søren Cold, Ann S. Knoop, Henrik J. Ditzel
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3569.
https://doi.org/10.1158/1078-0432.CCR-15-0776
Published: 02 August 2015
View article titled, Detecting Plasma Tumor DNA in Early-Stage Breast Cancer—Letter
Open the PDF for Detecting Plasma Tumor DNA in Early-Stage Breast Cancer—Letter in another window
Journal Articles

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer

Tom Donnem, Sigurd M. Hald, Erna-Elise Paulsen, Elin Richardsen, Samer Al-Saad, Thomas K. Kilvaer, Odd Terje Brustugun, Aslaug Helland, Marius Lund-Iversen, Mette Poehl, Karen Ege Olsen, Henrik J. Ditzel, Olfred Hansen, Khalid Al-Shibli, Yury Kiselev, Torkjel M. Sandanger, Sigve Andersen, Francesco Pezzella, Roy M. Bremnes, Lill-Tove Busund
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (11): 2635–2643.
https://doi.org/10.1158/1078-0432.CCR-14-1905
Published: 31 May 2015
View article titled, Stromal CD8<sup>+</sup> T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer
Open the PDF for Stromal CD8<sup>+</sup> T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data